Drawing for TAURPACK

USPTO serial 79247928

TAURPACK

Reviewed by CopyMark Law Group

Reg. 6522541Status 700Renewal
Filing date
Status date
Registration date
Oct 19, 2021
Examiner
ABRAMS, JACQUELINE WILLETTE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TAURPACK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 13, 2026IRFIIRREGULARITY ON FINAL DECISION RECEIVED FROM IB—
Mar 30, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Mar 30, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Jan 19, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 19, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 7, 2021GPNXNOTIFICATION PROCESSED BY IB—
Aug 3, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 3, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 14, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 14, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 14, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 2, 2021MREINOTICE OF REINSTATEMENT E-MAILED—
Jul 1, 2021CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Jun 29, 2021REINREINSTATED—
Sep 25, 2020CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
May 30, 2019DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
May 29, 2019DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 2, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 23, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 21, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 21, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 18, 2019ALIEASSIGNED TO LIE—
Feb 15, 2019RFNTREFUSAL PROCESSED BY IB—
Feb 12, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 18, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 18, 2019RFRRREFUSAL PROCESSED BY MPU—
Jan 8, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 7, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 31, 2018DOCKASSIGNED TO EXAMINER—
Dec 31, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 27, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 20, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance